OR WAIT null SECS
The new scientific advisory board will oversee innovation projects, identify and develop key new technologies, and be responsible for forming high-caliber alliances with innovative start-ups.
On Dec. 28, 2019, Sartorius announced that it has established a scientific advisory board for its corporate research activities, which will oversee overarching innovation projects. The scientific advisory board will be tasked with identifying and developing key technologies and application fields of the future and establishing a number of high-caliber alliances with start-up companies as well as other partners who contribute to innovation in the life science sectors.
“The unbiased advice of the [s]cientific [a]dvisory [b]oard will support Sartorius in maintaining a diverse, external view of trends in the industry and in guiding Sartorius' technological initiatives,” said Executive Board Chairman and CEO Dr. Joachim Kreuzburg, in a company press release.
“The members of the [s]cientific [a]dvisory [b]oard are leading experts in a diverse range of life science areas, including cell therapy processing, cell line engineering, stem cells, cell analytics, and biosensors. We are delighted to have such a strong group of individuals join our [board],” added Professor Oscar-Werner Reif, PhD, Sartorius’ chief technology officer and head of corporate research, in the press release.
The members of Sartorius’ scientific advisory board include: